Coronavirus, page-4

CSL is not the only company supplying influenza vaccines in Australia.

https://www.tga.gov.au/alert/2019-seasonal-influenza-vaccines

Registered products

For the 2019 influenza season, the TGA has registered six vaccines which will be available for use in the following age groups:

Sponsor	Tradename	Age group
Quadrivalent vaccines
Sanofi-Aventis	FluQuadri Junior	6-35 months* (<3 years)
	FluQuadri	3 years and over
GlaxoSmithKline	Fluarix Tetra	6 months and over**
Mylan Health	Influvac Tetra	18 years and over***
Seqirus	Afluria Quad	5 years and over
Trivalent vaccines
Seqirus	Fluad	65 years and over
Sanofi-aventis	Fluzone high dose	65 years and over***

• * Guidance for the dose in children aged 6–35 months is available in theProduct Information.
• ** A full 0.5 mL dose is now to be used in all age groups 6 months and over
• *** For private market only, not funded under the National Immunisation Program (NIP).

For further information on individual vaccines, please refer to the relevantProduct Information documentorConsumer Medicine Informationdocument.

The 2019 seasonal influenza vaccines will be available through the NIP from mid-April 2019.

In conjunction with the Office of Health Protection and state and territory health authorities, the TGA will be closely monitoring adverse event reports during the 2019 influenza vaccination program.

All influenza vaccines available this year are Latex free.